- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- 30K pounds of hospital grown food: How farmers figure into Trinity’s prescriptions
- ¿Qué tan bajo se puede llegar? Las cambiantes guías para el control de la presión arterial
- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- Even With Dental Insurance, You Still Could Face a Large Bill
- FDA solicits feedback on controversial national priority voucher review pathway
- Health Tech Weekly Rundown: Perplexity rolls out AI-powered medical records search; Doximity survey examines how docs use AI
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- The explosion of the Medicare Advantage special needs plan
- We’re Great Thinkers…But Not Rethinkers
- North Star to cut additional jobs
- North Star to cut additional jobs
- Oregon Governor asks PeaceHealth to delay contract switch: 11 things to know
- 6 Optum updates to know from Q1
- Viewpoint: US nursing workforce faces several risks
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- ‘The 1980s called’: CMS to phase out fax, mail
- Aligning IT & clinical teams: How to reduce friction and improve communication
- AI tool targets billing gaps at Kentucky system
- AI in pharmacy: Why pilots stall at hospitals
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- Michigan bills target outpatient fees, CON requirements
- Anesthesia group, lawmakers oppose Medicare cuts to non-opioid pain treatment
- Iowa lifts emergency suspension of transplant surgeon’s license
- Vascular center, physician CEO to pay $4M to settle fraud allegations
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- 5 cardiologists stepping into leadership roles
- New York organizations partner on intellectual, developmental disabilities campus
- Cincinnati hospital acquires outpatient center for $6M
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- MD Anderson opens colorectal cancer center
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- Fitch downgrades HonorHealth’s credit rating
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- Does Closing Your Eyes Help You Hear Better?
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- PrescriberPoint's solution to the modern prescribing journey
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- How CVS Caremark Is Shaping the Future of Pharmacy Benefits
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Beyond payment integrity: An AI-driven approach to affordability
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- healow Genie AI Contact Center Helped Manage 76% of Calls—Demonstrating That Patient Access and Operational Efficiency Go Together
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
National Institutes of Health (NIH) Director Jay Bhattacharya was on the receiving end of a diversity, equity and inclusion (DEI) firestorm during the COVID panic. He firmly believes the scientific approach to turn discoveries into better health has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI).
Here is his action plan:
https://thespectator.com/topic/cured-dei-national-institutes-health-jay-bhattacharya-matthew-memoli/
How we cured DEI at the National Institutes of Health
Scientists no longer have to mouth DEI shibboleths to garner funding
By Jay Bhattacharya and Matthew J. Memoli - December 11, 2025Since the National Institutes of Health was founded as a one room laboratory in 1887 its mission was simple; perform biomedical research to enhance health, lengthen life and reduce illness and disability for Americans. Scientists for more than one hundred years have taken this scientific approach to turn discoveries into better health. This mission unites all Americans of every race, color and creed. Everyone wants science that benefits their health.
Over the last decade and a half this mission has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI). This political ideology was reflected in all aspects of the NIH, including hiring practices, promotion and tenure, employee training, performance reviews, communications, management and, yes, even science.
For its entire history NIH funding decisions were made to reach scientific goals. DEI drove decisions to be made to reach political goals instead, requiring NIH scientists to write DEI statements – de facto loyalty oaths – and researchers outside the NIH applying for grants to write plans for enhancing “diverse perspectives” (another name for a DEI statement). Scientific reviewers were chosen based on DEI criteria, and those making funding decisions received bonuses for promoting DEI.
At the end of every fiscal year, NIH program officers handed out “diversity supplements” to universities, directing money to training programs based partly on scientists’ race, rather than their scientific ability. In 2022, the NIH announced funding for universities to conduct “system-wide” DEI audits to address “shortcomings” in addressing “structural racism.”
Scientists learned that the best way to maximize their chance of a slice of NIH money was to promise that their work would help achieve racial nirvana, however remote from utopian ideological pursuits the proposed work actually was. Most scientists obsequiously complied to avoid the risk of career harm, whether they were true believers or not.
NIH policy was fundamental in the DEI-ification of the nation’s top universities and research centers. Even before the fevered days of 2020, when the mania for DEI at universities reached a fever pitch, scientists were often required to write DEI loyalty oaths to be hired or promoted.
In 2020, at Stanford University, radical students circulated a blacklist of professors they considered guilty of wrongthink and harassed them for their ideological impurity. The administration published an “elimination of harmful language” banned word list, creating a hostile work environment for those whose beliefs fell outside the bounds of orthodox DEI-ism. All of this occurred with the approval and even applause of university leaders. Stanford was not alone; top universities embraced similar policies.
None of this reorientation of the NIH and the universities toward DEI translated into improving the health status of Americans. Between 2011 and 2019, life expectancies of nearly every racial group in the US flatlined. All Americans shared in the expanding chronic disease crisis that has made America among the least healthy economically developed nations on earth. Chronic disease does not discriminate and DEI is not the solution.
NIH’s devotion to DEI ended when President Trump took office in January 2025. At the NIH, we dismantled the DEI apparatus and refocused the NIH on its age-old mission. We oversaw a large-scale effort by all parts of NIH to eliminate DEI from its processes, including eliminating loyalty oaths and other DEI statements, removing DEI from performance reviews, hiring and promotion, and purging DEI from all facets of scientific review, notices of funding opportunity (NOFO) and grant decision making.
Though activist courts have restricted our ability to excise many DEI-focused grants from our portfolio, NIH has now terminated hundreds of NOFOs and modified the terms of more than 6,000 grants that contain unscientific DEI-related statements, projects and methods. Because DEI was so deeply embedded in the NIH’s portfolio, it will take some time to complete the work, but by the end of this fiscal year, we will have restored merit and science-based research to their rightful place at the NIH.
We continue to enthusiastically support research that advances the health of all Americans, regardless of their age, race, ethnicity, sex, sexual orientation, or other characteristics. We will unapologetically invest in rigorous science – research that genuinely improves the health of minority populations, rather than serving political ideologies that misuse taxpayer resources.
The NIH will not fund research based on ideologies that promote differential treatment of people based on race or ethnicity, nor will we fund studies exploring broad, poorly defined concepts such as racial microaggressions or implicit bias. Such work diverts resources away from projects that advance the health and longevity of all Americans, including minority populations.
So that the NIH never again strays from its mission, we have established new formal priorities for the NIH, with DEI removed and gold standard science leading the way. Scientists will no longer have to mouth DEI shibboleths to garner funding but instead propose excellent science that helps make America healthy again.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














